| 40513 |
CABOZANTINIB FUMARATE | II | A | MSN LABORATORIES PRIVATE LTD | 2024-09-30 |
| 39785 |
CABOZANTINIB (S)-MALATE | II | A | SICHUAN ELIXIR PHARMACEUTICAL CO LTD | 2024-03-26 |
| 39757 |
CABOZANTINIB SULFATE | II | A | SICHUAN ELIXIR PHARMACEUTICAL CO LTD | 2024-03-22 |
| 39274 |
CABOZANTINIB (S)-MALATE (FORM N-2) | II | A | DR REDDYS LABORATORIES LTD | 2023-12-29 |
| 39141 |
CABOZANTINIB INTERMEDIATE (CZT3) | II | A | DR REDDYS LABORATORIES LTD | 2023-12-01 |
| 38057 |
CABOZANTINIB-(S)-MALATE | II | A | BIOCON LTD | 2023-09-28 |
| 38207 |
CABOZANTINIB HYDROCHLORIDE | II | A | DR REDDYS LABORATORIES LTD | 2023-03-31 |
| 36509 |
CABOZANTINIB (S)-MALATE | II | A | NATCO PHARMA LTD | 2022-02-28 |
| 34437 |
CABOZANTINIB S-MALATE | II | A | FERMION OY | 2020-02-25 |
| 34201 |
CABOZANTINIB-S-MALATE | II | A | SUN PHARMACEUTICAL INDUSTRIES LTD | 2019-11-06 |
| 33349 |
METHYL 1-[(4-FLUOROPHENYL)CARBAMOYL]CYCLOPROPANE CARBOXYLATE (CABOZANTINIB INTERMEDIATE) | II | A | EMNAR PHARMA PRIVATE LTD | 2018-11-27 |
| 33137 |
CABOZANTINIB (S)-MALATE (FORM-S) | II | A | MSN LABORATORIES PRIVATE LTD | 2018-09-01 |
| 31522 |
CABOZANTINIB (S)-MALATE | II | A | MSN LABORATORIES PRIVATE LTD | 2017-03-30 |
